Merck held talks to buy Swiss biotech MoonLake for more than $3bn
US pharmaceuticals group has been looking to rebuild its pipeline before crucial cancer drug comes off-patent
You are not logged in so some information on this page has been withheld. To see more, please log in.
Merck
since
auto-detected in 107 stories
2 days ago
23 days ago
Stocks making the biggest moves midday: Amazon, Alibaba, Merck, Five Below, Nike and more
These are the stocks posting the largest moves in midday trading.
41 days ago
Merck lowers profit outlook, partly due to $200 million expected tariff hit
Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trump's planned pharmaceutical tariffs.
Merck lowers profit outlook, partly due to $200 million expected tariff hit
Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trump's planned pharmaceutical tariffs.
64 days ago
Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
AstraZeneca's new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.
3 months ago
Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook
Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 billion.
Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook
Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 billion.
Merck's 2025 revenue outlook falls short as it pauses Gardasil vaccine shipments to China
Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 billion.
Merck's 2025 revenue outlook falls short as it pauses Gardasil vaccine shipments to China
Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 billion.
4 months ago
Kennedy vows to keep vaccine suit stake if confirmed as US health chief
found
a story from Financial Times ✅ › Financial Times
Nominee says he is entitled to 10% of proceeds if case against Merck’s Gardasil treatment succeeds